ClinicalTrials.gov
public full text
Public Domain
Antihistamines, Amantadine and Evolution of COVID-19
The rates of symptomatic COVID19 infection, hospital admission among COVID19 cases and survival would be quantified in patiens chronically treated with antihistamines or amantadine, with the aim of determining the role of antihistamines and amantadine in the evolution of COVID19.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection#889203
- Microecology and Host Immunity in Patients With Severe COVID-19 Infection#1183031
- Prevalence of Myocardial Scars on CMR After COVID-19 Infection#1072118
- Follow-up of Covid-19 Long Term Sequelae#1074630
- Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel#832050
Record · ID 1320673
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive